← All stories
Markets
Can OptiBiotix Health (LSE:OPTI) Turn Microbiome Science Into Repeatable Licensing Income?
Highlights Revenue grew and gross margin improved sharply in the reported year A central London investor presentation and SweetBiotix sampling event was arranged The group holds interests spanning skincare and probiotics alongside its core…
Covered by 1 outlet
All coverage · 1 article